Kraig Biocraft Laboratories, Inc. (KBLB)
OTCQB OTCQB Primary Summary
KBLB Chart
24/7 Market News - Kraig Biocraft Advances Toward First-Ever Spider Silk Deliveries to Luxury and Performance Giants
Shareholder Letter Reveals Breakthroughs, Global Brand Engagement, and Commercial Readiness Denver, Colorado--(Newsfile Corp. - June 3, 2025) - 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and information, features the key highlights from a compelling shareholder letter by Kim Thompson, the CEO of Kraig Biocraft Laboratories (OTCQB: KBLB), the undisputed global leader in the development and commercialization of spider silk. The letter detailed groundbreaking scientific advancements, robust production progress, and a commercial pivot toward high-profile global partnerships, including these key takeaways: Kraig Biocraft Laboratories Logo Global Brands Standing by for First Spider Silk Shipments Kraig Labs entered active commercial discussions with three major global brands that are preparing to receive initial spider silk shipments.
Kraig Biocraft Laboratories Issues a Letter to Shareholders on Recent Advancements and Potential Recombinant Spider Silk Deliveries in 2025
Kraig Labs (OTCQB: KBLB) released a CEO letter packed with significant progress in production, R&D, and commercial developments for a transformative 2025
Kraig Biocraft Laboratories Announces New Spider Silk Parental Strain for Expanded Commercial Production
ANN ARBOR, Mich., May 28, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, announces today the successful development of a new recombinant spider silk parental line, purpose-built for large-scale commercial production.
Kraig Biocraft Laboratories, Inc. Dividends
Kraig Biocraft Laboratories, Inc. Earnings
| 12 May 2025 Date | | - Cons. EPS | - EPS |
| 31 Mar 2025 Date | | - Cons. EPS | - EPS |
| 11 Nov 2024 Date | | - Cons. EPS | - EPS |
| 14 Aug 2024 Date | | - Cons. EPS | - EPS |
| 13 Aug 2024 Date | | - Cons. EPS | - EPS |
| 12 May 2025 Date | | - Cons. EPS | - EPS |
| 31 Mar 2025 Date | | - Cons. EPS | - EPS |
| 11 Nov 2024 Date | | - Cons. EPS | - EPS |
| 14 Aug 2024 Date | | - Cons. EPS | - EPS |
| 13 Aug 2024 Date | | - Cons. EPS | - EPS |
Kraig Biocraft Laboratories, Inc. (KBLB) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Kraig Biocraft Laboratories, Inc. ever had a stock split?
Kraig Biocraft Laboratories, Inc. Profile
| Specialty Chemicals Industry | Basic Materials Sector | Mr. Kim Kraig Thompson CEO | OTCQB Exchange | US50075W1045 ISIN |
| US Country | 37 Employees | - Last Dividend | 28 May 2009 Last Split | - IPO Date |
Overview
Kraig Biocraft Laboratories, Inc. is a pioneering company focused on the development of protein-based fibers for a broad range of commercial applications within the technical textile and specialty fiber industries. Founded in 2006 and headquartered in Ann Arbor, Michigan, the company harnesses recombinant DNA technology to innovate in the field of biotechnology. Its research efforts are primarily centered around the production of natural and engineered variants of spider silk, utilizing domesticated mulberry silkworms that have been genetically modified to produce spider silk proteins. This cutting-edge technology aims to create recombinant spider silk fibers that boast superior strength, flexibility, and a wide array of applications, from military and defense to medical textiles.
Products and Services
The product line of Kraig Biocraft Laboratories, Inc. extends across various industries, leveraging the unique properties of spider silk for diverse applications:
- Military and Police Ballistic Protection: Using recombinant spider silk, the company develops body armor and other protective textiles designed to offer enhanced protection against ballistic threats, combining lightweight design with strong and resilient fibers for maximum safety and comfort in law enforcement and military applications.
- Industrial Applications: The company's fibers find utility in manufacturing critical cables and components that require high levels of abrasion and impact resistance. These applications demonstrate the material's durability and strength in industrial settings, including but not limited to construction and machinery.
- Safety Equipment: Spider silk's toughness and flexibility are harnessed to create advanced safety equipment, including but not limited to, helmets, protective gloves, and gear for high-risk work environments, contributing to greater worker safety and security.
- Aerospace Composites: The aerospace industry benefits from the lightweight and high-strength characteristics of spider silk-based materials. Kraig Biocraft Laboratories contributes to the development of composite materials that are used in the construction and reinforcement of aerospace components, enhancing their performance and reliability.
- Medical, Geotextiles, and More: The company's innovations extend to medical textiles, geotextiles, defense and military textiles, safe and protective clothing, filtration textiles, composites with textile structure, and functional and sportive textiles. Additionally, its products are valuable in the construction of textiles used in buildings and transportation, showcasing the versatility and wide-ranging potential of recombinant spider silk in various market segments.
Contact Information
